menu
    • menu

    Company profile for BioCardia

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage regenerative medicine company with a mission, to bring to market comprehensive cell therapy solutions for the treatment of cardiovascular diseases with large unmet medical needs. Our Pipeline: Our lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System, which provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinic...
    We are a clinical-stage regenerative medicine company with a mission, to bring to market comprehensive cell therapy solutions for the treatment of cardiovascular diseases with large unmet medical needs. Our Pipeline: Our lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System, which provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications - heart failure that develops after a heart attack and chronic myocardial ischemia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioCardiaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    125 Shoreway Road, SuiteB San Carlos, CA
    Telephone
    Telephone
    (800) 624-1179
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocardia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCardia to Present at 2025 CSI Heart Failure Focus
    BioCardia to Present at 2025 CSI Heart Failure Focus

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197000/0/en/BioCardia-to-Present-at-December-2025-CSI-Focus-Devices-in-Heart-Failure-Congress.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Biocardia Appoints Farhan Shahab As VP Of Quality
    Biocardia Appoints Farhan Shahab As VP Of Quality

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193476/0/en/BioCardia-Strengthens-Leadership-Team-with-The-Addition-of-Farhan-Shahab-as-Vice-President-of-Quality.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Biocardia Highlights Q3 2025 Business & Financial Results
    Biocardia Highlights Q3 2025 Business & Financial Results

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186852/0/en/BioCardia-Reports-Third-Quarter-2025-Business-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Biocardia Enrolls First Patient In Phase 3 CardiAMP HF II Trial
    Biocardia Enrolls First Patient In Phase 3 CardiAMP HF II Trial

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184584/0/en/BioCardia-Announces-Henry-Ford-Health-Enrolls-Their-First-Patient-in-Phase-3-CardiAMP-HF-II-Cell-Therapy-Pivotal-Trial.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Biocardia To Host Q3 2025 Corporate Update Conference Call
    Biocardia To Host Q3 2025 Corporate Update Conference Call

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182124/0/en/BioCardia-to-Host-Q3-2025-Corporate-Update-and-Financial-Results-Conference-Call-on-November-12-2025.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Biocardia Enrolls First Patient In Phase 3 Cardiamp HF II Trial
    Biocardia Enrolls First Patient In Phase 3 Cardiamp HF II Trial

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177310/0/en/BioCardia-Announces-University-of-Wisconsin-Enrolls-Their-First-Patient-in-Phase-3-CardiAMP-HF-II-Cell-Therapy-Pivotal-Trial.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search